Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00936351 · ClinicalTrials.gov registry record · NA
Mindfulness Meditation as a Rehabilitation Strategy for Persons With Schizophrenia
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT00936351: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT00936351 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00936351, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a treatment manual for mindfulness meditation to be taught in a group format to individuals with schizophrenia who are engaged in vocational rehabilitation. This study will also determine whether mindfulness meditation is beneficial in terms of improving work function by reducing distressing emotional states and thinking patterns.
Primary Outcome
total hours worked over the duration of the 24-week treatment
Interventions
- BEHAVIORAL Mindfulness Meditation
- BEHAVIORAL Support Group (control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-12 |
| Phase | NA |
What the finished NCT00936351 record still lists
NCT00936351 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Mindfulness Meditation is the first listed.
NCT00936351 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00936351 about?
NCT00936351 is a clinical study titled "Mindfulness Meditation as a Rehabilitation Strategy for Persons With Schizophrenia". The purpose of this study is to develop a treatment manual for mindfulness meditation to be taught in a group format to individuals with schizophrenia who are engaged in vocational rehabilitation. This study will also determine whether mindfulness meditation is beneficial in terms of improving work ...
What is the current status of trial NCT00936351?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2007-12. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00936351?
The interventions under investigation include: Mindfulness Meditation (BEHAVIORAL), Support Group (control) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00936351?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00936351's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia